Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Triacylglycerol Digestion”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 0 results

Not applicableStudy completedNCT05044130
What this trial is testing

Postprandial VLDL-triglyceride Metabolism in Type 2 Diabetes Patients With and Without NAFLD

Who this might be right for
NAFLDType 2 Diabetes
University of Aarhus 17
Testing effectiveness (Phase 2)Study completedNCT01625026
What this trial is testing

Obeticholic Acid in Bariatric and Gallstone Disease

Who this might be right for
ObesityGallstones
Sahlgrenska University Hospital 40
Not applicableUnknownNCT01363791
What this trial is testing

Meta-analyses of Fructose and Cardiometabolic Risk

Who this might be right for
DyslipidemiaDiabetesPrediabetes+8 more
John Sievenpiper 1
Large-scale testing (Phase 3)Study completedNCT01418027
What this trial is testing

Combined Intensive and Conventional Exercise on Nonalcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)
Shanghai Jiao Tong University School of Medicine 220
Testing effectiveness (Phase 2)Study completedNCT01094158
What this trial is testing

Study of Aramchol in Patients With Fatty Liver Disease or Nonalcoholic Steatohepatitis

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNonalcoholic SteatohepatitisMetabolic Syndrome
Galmed Medical Reserch 60
Not applicableStudy completedNCT00594412
What this trial is testing

MRI to Measure Liver Fat Content

Who this might be right for
Fatty LiverHepatitis
National Institute of Allergy and Infectious Diseases (NIAID) 53
Post-approval studies (Phase 4)Ended earlyNCT01355575
What this trial is testing

Rifaximin in Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver DiseaseNAFLDNonalcoholic Steatohepatitis
Imperial College London 15